the third-leading cause of cancer deaths globally – emerges from advanced liver fibrosis or cirrhosis. A comprehensive review ...

Researchers decode how liver fibrosis progresses to cancer, identifying key cellular drivers and signaling pathways. The review highlights promising biomarkers for early detection and novel ...

World Hepatitis Day is observed on July 28, and is a crucial reminder to take proactive steps against hepatitis, a silent ...

Background The Surprise Question, ‘Would you be surprised if this person died within the next year?’ is a simple tool that can be used by clinicians to identify people within the last year of life.

8 European Foundation for the Study of Chronic Liver Failure (EF CLIF), Barcelona, Spain Background Acute-on-chronic liver failure (ACLF) of various aetiologies is a complex syndrome with high ...

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of the general population and is the fastest growing cause of hepatocellular carcinoma (HCC). Current ...

Epidemiological transition of metabolic dysfunction-associated steatotic liver disease-related chronic liver disease and cirrhosis: a comparative study between China and the global population ...

Introduction Liver cirrhosis and other chronic liver diseases is a serious public health problem, and its incidence, morbidity, and mortality have increased in recent years (1). In 2019, 1691.0 ...

HHS Secretary Robert F. Kennedy Jr. and the CDC vaccine panel have been casting doubt on the hepatitis B shot and the practice of vaccinating newborns.

An intelligence assessment after the election found that Russia waged an information warfare campaign designed to boost Trump’s prospects and damage Hillary Clinton's candidacy.

With the rapid development of global metal exposure, while there is evidence indicating the toxicity of individual metals, the combined impact of mixed exposure of multiple metals on primary liver ...

In patients with HF with mildly reduced or preserved ejection fraction, mineralocorticoid receptor antagonist initiation without worsening renal function, but not with worsening renal function, during ...